Skip to main content
ConductScienceScienceDex

Andrew E. Levin

NIH Rank #1294
Unclaimed recordClaim profile
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7895207Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$5.2M
Full award amounts, FY2025
Award Records
8
Records listing this PI
Award-Linked Rank
#1,294
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Andrew E. Levin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Andrew E. Levin as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI136172-05R44
    Point-of-care diagnostic test for T. cruzi (Chagas) infection
    Kephera Diagnostics, Llc
    $1M
    award amount
  • 1R44HL180181-01R44
    Peptide-based ELISA for laboratory diagnosis of sarcoidosis
    Kephera Diagnostics, Llc
    $978.2K
    award amount
  • 5R44AI147973-05R44
    Biomarker-Based Test of Cure for Chagas Disease
    Kephera Diagnostics, Llc
    $906K
    award amount
  • 5R44AI149903-05R44
    Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
    Kephera Diagnostics, Llc
    $876.4K
    award amount
  • 5R44AI142903-05R44
    Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
    Kephera Diagnostics, Llc
    $714.7K
    award amount
  • 5R43AI181234-02R43
    Diagnostic assay for congenital Chagas disease
    Kephera Diagnostics, Llc
    $303.3K
    award amount
  • 75N93025C00003-0-9999-1N01
    NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR SELECT NEGLECTED TROPICAL DISEASES
    Kephera Diagnostics, Llc
    $300K
    award amount
  • 3R44AI149903-05S1R44
    Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
    Kephera Diagnostics, Llc
    $123.6K
    award amount

Award organization

Organizations that administered FY2025 awards listing Andrew E. Levin as a PI.

FY2025 award administered by Kephera Diagnostics, Llc (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Kephera Diagnostics, Llc
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1129
  6. 2024
    Entered Top 25% Nationally
    Ranked #1129
  7. 2024
    Entered Top 10% Nationally
    Ranked #1129
  8. 2025
    $5M Cumulative Funding
  9. 2025
    $10M Cumulative Funding

Explore further

Find collaborators for Andrew E. Levin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →